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Abstract
Objectives—While some eruption disorders occur as part of a medical syndrome, primary
failure of eruption (PFE) – defined as a localized failure of secondary tooth eruption -exists
without systemic involvement. Recent studies support that heredity may play an important role in
the pathogenesis of PFE. The objective of our human genetic study is to investigate the genetic
contribution to PFE.
Materials and Methods—Four candidate genes POSTN, RUNX2, AMELX, and AMBN) were
investigated due to their relationship to tooth eruption or putative relationship to each other.
Families and individuals were ascertained based on the clinical diagnosis of PFE. Pedigrees were
constructed and analyzed by inspection to determine the mode of inheritance in 4 families. The
candidate genes were directly sequenced for both unrelated affected individuals and unaffected
individuals. A genome wide scan using 500 microsatellite markers followed by linkage analysis
was carried out for one family.
Results—Pedigree analysis of families suggests an autosomal dominant inheritance pattern with
complete penetrance and variable expressivity. Sequence analysis revealed 2 non-functional
polymorphisms in the POSTN gene and no other sequence variations in the remaining candidate
genes. Genotyping and linkage analysis of one family yielded a LOD score of 1.51 for markers
D13S272; D15S118 and D17S831 on chromosomes 13, 15 and 17 respectively.
Conclusions—While LOD scores were not significant evidence of linkage, extension of current
pedigrees and novel SNP chip technology holds great promise for identification of a causative
locus for PFE.
Clinical Relevance—When the process of normal tooth eruption fails, it may result in a
clinically guarded or hopeless prognosis. Our studies aim to understand the etiological basis of
Primary Failure of Eruption (PFE) toward the development of future orthodontic or
pharmocologic interventions that will successfully treat this problem.
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Cellular and molecular advances in osteoclastogenesis have increased our understanding of
the mechanisms controlling tooth eruption. As a result of recent studies in mice (1), we
know that normal tooth eruption is a temporally coordinated process in which the dental
follicle interacts with both osteoclasts and osteoblasts. A disturbance of this process can
occur secondary to a blocked eruption path (mechanical failure of eruption) or as a primary
failure of the eruption apparatus itself (primary failure of eruption). Primary Failure of
Eruption (PFE), first described by Proffit and Vig (2), is defined as a localized eruption
failure of permanent teeth - even when subject to orthodontic force. Recent clinical
characterization has revealed that several types of non-syndromic PFE exist including
familial and non-familial forms affecting posterior segments either unilaterally or bilaterally
(3). However, whether it is part of a medical syndrome or a sporadic event, eruption failure
is likely a heritable trait and the elucidation of its genetic contribution will undoubtedly lead
to improved diagnosis and treatment approaches.
Surgical studies in dogs provided initial evidence that the role of the dental follicle was
central to the eruption process - if the follicle was removed eruption failed, but if left intact
without a tooth, eruption occurred (4). Hence, the dental follicle plays an important role by
initiating the coordinated process of alveolar bone resorption and apposition necessary to
allow a tooth to move through bone. Our current understanding of the genetic and molecular
control of tooth eruption has largely stemmed from studies in mice (5). For example,
osteopetrotic mice (6,7,8) and RANKL knockout mice (9) have an eruption failure
phenotype, but injection of CSF-1 into these animals at a developmental age prior to the
onset of eruption induces eruption (10).
Advances in molecular biology have contributed to our understanding of the
microenvironment surrounding tooth eruption. For instance, the complex relationship
between receptor activator of nuclear factor kB ligand (RANK-L) and macrophage-colony
stimulating factor (CSF) in the formation and activation of osteoclasts has been well-
described (5) and makes them potential candidates genes for PFE. However, the search for
candidate genes responsible for PFE still presents a unique challenge since this dental
condition presents in the absence of any systemic disorders. Hence, the consideration of
‘tooth-specific’ genes, or those genes not implicated in systemic conditions, becomes a high-
priority in evaluating candidate genes for PFE. For instance, gene products of Periostin
(POSTN), Amelogenin (AMELX), and Ameloblastin (AMBN) play an important role in tooth
developmental processes and provide interesting candidates for eruption failure for many
reasons. AMELX, an enamel matrix protein, was shown to be a negative regulator of
osteoclastogenesis inhibiting the expression of RANKL, M-CSF (11). One study revealed
that although AMBN and AMELX are important for mineralization, both also share a role in
the development and regeneration of the periodontal ligament (12) making either potential
candidate genes for eruption disorders. Periostin, initially identified as osteoblast-specific
factor-2, was renamed periostin to avoid its confusion with a transcription factor, Cbfa1
(13). Periostin null mice showed an eruption failure when compared to wild-type mice (14).
Finally, we propose another potential candidate gene, RUNX2. Although previous studies
confirm the role of RUNX2 (also referred to as CBFA1) in both dental and skeletal defects
seen in cleidocranial dysplasia (CCD) - including abnormal somatic bone development,
absence of clavicles, supernumerary teeth and eruption delay - one study extended the CCD
phenotypic spectrum to include a dental phenotype with a radiologically normal skeleton
(15). This evidence that an isolated dental phenotype (supernumerary teeth) can result from
a RUNX2 mutation provides compelling rationale for choosing it as a candidate gene for
eruption failure.
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The objective of our study is to define the genetic contribution of eruption failure in humans
and to test the hypothesis that human PFE is due to one or more distinct mutations in key
candidate genes. Our rationale for investigating the genetic etiology of the PFE is based on
studies in mice that confirm the role of several candidate genes in eruption failure and
studies in humans that show the segregation of this trait in families.
Materials and Methods
Diagnosis and inheritance of clinical eruption failure phenotype
Approval for this study was granted by the Biomedical Institutional Review Board at the
University of North Carolina at Chapel Hill. Consent to participate (including a release for
dental records) was obtained from every adult participant or from a parental guardian in the
case of minors. Individuals and families were recruited based on the presence of the PFE.
Through subsequent interviews, pedigrees (Fig. 1A–D) were extended for a total of 17
individuals from 4 families. There was also one individual evaluated who did not report
affected relatives. Family A consisted of 12 individuals (9 were available for clinical and
molecular studies); family B consisted of 13 members (3 were available for clinical and
molecular studies); Family C consisted of 12 individuals (3 were available for clinical
studies); and Family D consisted of 44 individuals according to the proband and historian (2
were available for clinical and molecular studies). The age range was from 5 – 72 years. A
total of 18 individuals (representative of 4 families and 1 isolated case) were available for
pre-treatment clinical photographs, panoramic and cephalometric radiographs following the
initial clinical evaluation. Briefly, the clinical evaluation was carried out as follows 1) a
positive diagnosis of the PFE was made for all available individuals based on the presence
of at least one unerupted tooth following unsuccessful orthodontic treatment in the absence
of any mechanical or secondary barrier; 2) skeletal relationships including vertical (overbite
or open bite) and sagittal (Angle’s Class I, Class II or Class III molar) were made based on
clinical exam and cephalometric radiographs; and 3) anomalies in growth and/or stature
were determined to be absent or present.
Sequencing and mutational analysis of candidate genes
Extraction and purification of DNA was carried out using buccal cell (PureGene kit, Gentra
Systems, MN) or saliva using Oragene kits (DNA Genotek, CA) for 6 of 18 individuals
analyzed above. Sequencing and mutational analysis was limited to selected individuals
(probands and isolated cases) since related individuals share the same genotype. High-
priority candidate genes were selected based on their relationship to tooth eruption or their
putative relationship to each other. PCR amplification of four candidate genes (POSTN
RUNX2, AMELX, and AMBN) was carried out for selected individuals (n=6) using primers
as shown in Table I (POSTN) or as described previously for AMLEX (16) RUNX2 and
AMBN (17). PCR was carried out using FailSafe PCR buffer (Epicentre Biotechnologies,
Madison, WI) and under the following conditions: 10 min 95°C activation/premelt step,
followed by 35 cycles of 30 s of 94°C melt, 30 s of 60°C anneal, and 3 min of 72°C
extension. PCR products were purified using ExoSaplt (USB, Cleveland OH), then
sequenced (Applied Biosystems, Foster City, CA) as recommended by the manufacturer.
Sequencing was performed at the UNC Genome Analysis Facility.
Genotyping and linkage analysis
Genotyping was carried using 500 microsatellite markers (deCODE Genetics, Reykjavik,
Iceland) via an automated 8 cM genome-wide microsatellite repeat scan for 9 individuals in
Family A (Fig. 1) that was judged adequate to show ‘suggestive’ evidence of linkage.
Diagnosis was made based on the dichotomous affection status (ie presence or absence of
PFE). Although for the purposes of future studies, patients were also diagnosed with specific
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types of PFE as described previously (3). Map distances were taken from the deCODE map
based on human genome build 36 at NCBI. Parametric and non-parametric (model free)
multipoint linkage analyses (18) were performed using Allegro software version 2.1 by
Allegro Microsystems, Inc., Worcester, MA (19). Non-parametric linkage (NPL) analysis
was run to account for the possibility of alternate modes of inheritance. NPL has been
described as a powerful approach compared to the commonly used parametric methods and
has been referred to as the method of choice for pedigree studies of complex traits (20). We
assumed an autosomal dominant inheritance with incomplete penetrance (97%) for the
parametric analysis and an affected allele frequency of 0.0001. Calculations using marker
allele frequencies were based on the allele frequencies generated from an Icelandic
population (Caucasian sample). Linkage calculations were made at 1cM intervals and LOD
scores generated for both parametric and non-parametric analyses.
Results
Phenotypic characterization
The initial diagnosis of PFE was made based on the sole criteria of ‘failure to erupt’
following orthodontic forces. The PFE affection status was used for subsequent linkage
studies, while additional phenotypic descriptions were made to fully characterize the
craniofacial features that may be associated with the PFE phenotype. Individuals were also
classified as PFE Type I, Type II, or combination as previously described (3). The
cephalometric and clinical evaluation for 18 individuals included an examination of vertical
and sagittal relationships and revealed that while more individuals also appeared Class III
the sample size was not statistically sufficient enough to evaluate whether a correlation
existed. Family A showed a co-segregation of the Class III and PFE traits.
Genotyping and linkage mapping
Pedigree analysis by visual inspection for 4 families suggests an autosomal dominant
inheritance with incomplete penetrance. The following criteria were used to distinguish
autosomal dominance from recessive patterns of inheritance: males and females are equally
affected; the phenotype appears in every generation; and (e) unaffected individuals do not
transmit the phenotype. In families B and C the second generation reported uncertainty
about the eruption phenotype and were not available for analysis. Families A and D most
resembled the autosomal dominant inheritance pattern.
Non-parametric linkage analysis revealed that 3 loci; 13q21, 15q11-q13 and 17p13.2 (Table
1) on 3 chromosomes were just under the threshold to be considered suggestive of linkage
using the criteria of a LOD threshold of 1.86 proposed by Rao and Gu (21) for suggestive
linkage in genome-wide linkage studies. We identified candidate genes of biologic interest
for 3 loci, 13q21; 15q11-q13 and 17p13.2 using bioinformatic approaches
(http://www.ncbi.nlm.nih.gov/projects/omim/Homology/). The candidate intervals described
above included a total of 749 genes (Table 2), but we determined that 7 genes were of
interest based on biological pathways or relationships to genes involved in tooth
development. Several other genes in candidate regions were either previously undescribed or
of unknown function. One of our goals was to try to exclude regions of key signaling
molecules in tooth development to narrow our search for candidate genes; however, we were
unable to exclude any regions (i.e., LOD = <-2.0) using our modest sample size (Family A).
Mutational analysis
Candidate gene analysis of POSTN, RUNX2, AMELX, and AMBN for both unrelated affected
individuals and unaffected individuals did not reveal functional polymorphisms or disease-
causing mutations. We did, however identify 2 polymorphisms in the intronic region of the
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POSTN gene for 1 affected non-familial individual with Type I PFE (Fig. 2). Using
bioinformatic approaches, we determined that the intronic polymorphisms identified, c.
1905+27G>A and c.2100+22G>A, 1) were not nonfunctional alterations, and 2) did not
abolish or create splice sites of POSTN.
Discussion
Our clinical and pedigree analysis findings support that theory that PFE is an inherited
disorder. Our mutational analysis and linkage studies may indicate regions that are linked to
the PFE trait. Specifically, we found that region 13q21 is in the vicinity of the POSTN locus
at 13q11.1 where we identified two intronic polymorphisms. While the candidate gene
analysis data was negative for the coding mutations in AMELX, AMBN, RUNX2 and
POSTN, we found it informative and encouraging for future genetic studies to identify 2
polymorphisms that are proximal to a candidate region suggestive of linkage. While our
linkage studies using the deCODE screen were not conclusive, the regions that we identified
using linkage analysis are just under the threshold of ‘suggestive’ for linkage and provide
potential regions for future studies with a larger and more informative sample size.
However, the most optimal approach is to identify large informative families and expand our
current pedigrees. This will provide the additional power needed to conclusively establish
linkage to causative genes, and also enable us to further refine correlations of PFE to other
features, such as Class III malocclusion.
An intriguing and critical issue to consider for future studies is the selection of high priority
candidate genes for further interrogation. These questions and many others were addressed
at the COAST conference where these proceedings were presented. In the absence of highly
significant LOD scores, finding the most relevant genes to pursue is an indeed a complex
task and to a large extent depends on our understanding of the biological event(s) creating
the ‘eruptive force’ that is lacking in PFE. Our evaluation of mineralization genes, while not
a logical first choice, may have great value. During the 2008 COAST conference Dr.
Malcom Snead suggested that genes involved in mineralization may act in concert with
those involved in osteoclastogenesis (RANKL, CSF1, Cfos, etc.). More specifically, his
theory purports that during the eruption of a tooth the osteoclastic activity might be
stimulated at the cessation of enamel formation, while enamel matrix gene expression is
winding down. Further, the lack of amelogenin degradation proteins causes a local
upregulation in RANKL and the osteolytic activity seen around the crown of the tooth.
RANKL is suppressed by amelogenin as shown by the amelogenin knock out that suffers
from increased osteoclastic and cemetoclastic activity (22). Hence the eruptive force is
provided by immigration of stem cells into the site, which either aids the osteoclastic activity
or enhances the ‘engine’ of eruption.
Researchers are rapidly working toward a complete understanding of the precise
coordination of molecular and cellular events surrounding eruption. A combination of
advances in genomics, proteomics and clinical sciences provide hope that future diagnostic
and clinical regimes will offer pharmacogenetic strategies to definitively reverse an
otherwise guarded or hopeless clinical prognosis.
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(A–D). Pedigrees of 4 families showing segregation of the PFE. Affection status is as
follows: darkened circles or squares denote an affected individual; clear denotes unaffected;
circles or squares with a question mark indicate affected status unknown. Squares indicate
male; circles indicate female; diagonal line indicates deceased.
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(A–B). Electrophlerograms of the POSTN sequence from a sporadic case (non-familial) of
PFE. Pairwise alignment using bioinformatic tools indicate 2 non-functional SNPs (as
labeled above) in the intronic region of POSTN.
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Table 1
Parametric and non-parametric linkage analyses reveal regions on Chromosomes 13q21; 15q11-q13 and
17p13.2.
Locus* Marker LOD+ ZLR# parametric (p)/non-para (npl)
13q21 D13S272 1.51 2.63 p
15q11-q13 D15S118 1.51 2.63 npl
17p13.2 D17S831 1.51 2.63 npl
*
Locus refers to map position as identified by MARKER
+
LOD denotes logarithm (base 10) of odds
#
ZLR refers to the maximum likelihood ratio z-score
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Table 2
Candidate intervals contain over 700 genes. Seven potential candidate genes were selected based on biologic
relevance.
Chromosome Region LOD #of genes in region Potential Candidates
13 D13S271-D13S272 1.51 84 Proximal region to POSTN
15 D15S118-D15S998 1.51 258 PACE4 - convertase involved in the processing of TGFB1
FGF7 - growth factor specific for epithelial cells
MYH12 - cellular proliferation or for the polarized movement
IGF1R - anti-apoptotic agent
17 17p11.2-ter 1.50 407 MYH2 - drives diverse motile processes such as cellular locomotion
MYH1 – similar to above
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APPENDIX
Human Periostin Primers
Primer pair Product size Forward primer Reverse Primer
1 227 GAGCTCTCCAAAGCCCACT GCTGAGGAAAAAGAAAAATGG
2 243 TCAACCAATCTTTAGATACGAAAA CAGGGGAAGGCATATACATCA
3 228 TCAACAAATCAAGTCAATAAGTGAAA AGCCACCTCAACCCTTTCTT
4 312 ATGTCTTGGGAAACACAGCA GTTAAAATGAAATAACAATAACAGCAA
5 395 CAAGAGAGTAGAAATAGGGTGATCG GCCCTAGATTTGGGGGTAAA
6 250 GTCAATGGGTATCTCTGGTTTC AGGAGAAGAAGAGGGATTTCA
7 283 TGTGTTGCAATCTTTTTCTGG TTGGTAAGGACTAGCCTCTTTTT
8 369 GGGTCAAATGTTATTTCCCTTG CTGCACATTCATTTTTCATGG
9 261 TGATGGAGATAATAGCAATGATGA TGCAAACAATCATCATAAAGAAAAA
10 278 ACCGGGAGAAACTTCAATGT TCATTGAAACAGCATTATTTGACA
11 244 GGGAAATTTCAAGCAAGGAA CAAAAATATGCCAATAGCTCTCA
12 250 CATGCACTGTAGGTGAACATACCT AAGTGAGATCCTGAAATGAAAGG
13 678 TGTTTCTTAGTCCTTATCAAAAAGTCA CTGAGATCATGCCACTGCAC
14 242 AGTGGTGCCATGGTTTTGTT TGAGATTGGCCATAGTTTGGA
15 281 AAAACCTTTGTTCAGGTTTTTATG TGAGCATGCCATTGGTATAA
16 238 TTGAGTCACACCGAATGTTGA TTCAAAATAATCACAGCGAAGG
17 217 TGGATGTATAGTCACAATATGAGGGTA TTTGGGGATTAACTATAATTTGATCTT
18 700 CATGGCCCACAAGTGTAAAA AAAATCTGCTTGCTCAGTCTTT
19 238 AACCATGGTCTCCTGTCTGA GGCTAGCTTTTCTCTCTGATCG
20 712 TGAAAGTAAAAGATCAACTGCACA ACAAGGCTCGGTCTTTTCAA
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